159 related articles for article (PubMed ID: 35764878)
1. A novel HRAS c.466C>T p.(Phe156Leu) variant in two patients with attenuated features of Costello syndrome.
Lindsey-Temple S; Edwards M; Rickassel V; Nauth T; Rosenberger G
Eur J Hum Genet; 2022 Sep; 30(9):1088-1093. PubMed ID: 35764878
[TBL] [Abstract][Full Text] [Related]
2. An attenuated phenotype of Costello syndrome in three unrelated individuals with a HRAS c.179G>A (p.Gly60Asp) mutation correlates with uncommon functional consequences.
Gripp KW; Sol-Church K; Smpokou P; Graham GE; Stevenson DA; Hanson H; Viskochil DH; Baker LC; Russo B; Gardner N; Stabley DL; Kolbe V; Rosenberger G
Am J Med Genet A; 2015 Sep; 167A(9):2085-97. PubMed ID: 25914166
[TBL] [Abstract][Full Text] [Related]
3. Attenuated phenotype of Costello syndrome and early death in a patient with an HRAS mutation (c.179G>T; p.Gly60Val) affecting signalling dynamics.
Gripp KW; Kolbe V; Brandenstein LI; Rosenberger G
Clin Genet; 2017 Sep; 92(3):332-337. PubMed ID: 28139825
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of a duplication (p.E63_D69dup) in the switch II region of HRAS: new aspects of the molecular pathogenesis underlying Costello syndrome.
Lorenz S; Lissewski C; Simsek-Kiper PO; Alanay Y; Boduroglu K; Zenker M; Rosenberger G
Hum Mol Genet; 2013 Apr; 22(8):1643-53. PubMed ID: 23335589
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic spectrum of Costello syndrome individuals harboring the rare HRAS mutation p.Gly13Asp.
Bertola D; Buscarilli M; Stabley DL; Baker L; Doyle D; Bartholomew DW; Sol-Church K; Gripp KW
Am J Med Genet A; 2017 May; 173(5):1309-1318. PubMed ID: 28371260
[TBL] [Abstract][Full Text] [Related]
6. Costello syndrome with special cutaneous manifestations and HRAS G12D mutation: A case report and literature review.
Qian W; Zhang M; Huang H; Chen Y; Park G; Zeng N; Li Y; Lu Q; Luo D
Mol Genet Genomic Med; 2021 Jun; 9(6):e1690. PubMed ID: 33932139
[TBL] [Abstract][Full Text] [Related]
7. Duplication of Glu37 in the switch I region of HRAS impairs effector/GAP binding and underlies Costello syndrome by promoting enhanced growth factor-dependent MAPK and AKT activation.
Gremer L; De Luca A; Merbitz-Zahradnik T; Dallapiccola B; Morlot S; Tartaglia M; Kutsche K; Ahmadian MR; Rosenberger G
Hum Mol Genet; 2010 Mar; 19(5):790-802. PubMed ID: 19995790
[TBL] [Abstract][Full Text] [Related]
8. A very mild phenotype in six individuals of a three-generation family with the novel HRAS variant c.176C > G p.(Ala59Gly): Emergence of a new HRAS-related RASopathy distinct from Costello syndrome.
Frey T; Ivanovski I; Bahr A; Zweier M; Laube J; Luchsinger I; Steindl K; Rauch A
Am J Med Genet A; 2023 Aug; 191(8):2074-2082. PubMed ID: 37194190
[TBL] [Abstract][Full Text] [Related]
9. HRAS mutants identified in Costello syndrome patients can induce cellular senescence: possible implications for the pathogenesis of Costello syndrome.
Niihori T; Aoki Y; Okamoto N; Kurosawa K; Ohashi H; Mizuno S; Kawame H; Inazawa J; Ohura T; Arai H; Nabatame S; Kikuchi K; Kuroki Y; Miura M; Tanaka T; Ohtake A; Omori I; Ihara K; Mabe H; Watanabe K; Niijima S; Okano E; Numabe H; Matsubara Y
J Hum Genet; 2011 Oct; 56(10):707-15. PubMed ID: 21850009
[TBL] [Abstract][Full Text] [Related]
10. Woolly hair nevus caused by somatic mutation and Costello syndrome caused by germline mutation in HRAS: Consider parental mosaicism in prenatal counseling.
Liang J; Guo Y; Lu Z; Yu H; Wu L; Yao Z
J Dermatol; 2022 Jan; 49(1):161-164. PubMed ID: 34601768
[TBL] [Abstract][Full Text] [Related]
11. The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in Cancer.
Hartung AM; Swensen J; Uriz IE; Lapin M; Kristjansdottir K; Petersen US; Bang JM; Guerra B; Andersen HS; Dobrowolski SF; Carey JC; Yu P; Vaughn C; Calhoun A; Larsen MR; Dyrskjøt L; Stevenson DA; Andresen BS
PLoS Genet; 2016 May; 12(5):e1006039. PubMed ID: 27195699
[TBL] [Abstract][Full Text] [Related]
12. A novel patient with an attenuated Costello syndrome phenotype due to an HRAS mutation affecting codon 146-Literature review and update.
Chiu AT; Leung GK; Chu YW; Gripp KW; Chung BH
Am J Med Genet A; 2017 Apr; 173(4):1109-1114. PubMed ID: 28328122
[TBL] [Abstract][Full Text] [Related]
13. Fetal costello syndrome with neuromuscular spindles excess and p.Gly12Val HRAS mutation.
Quélin C; Loget P; Rozel C; D'Hervé D; Fradin M; Demurger F; Odent S; Pasquier L; Cavé H; Marcorelles P
Eur J Med Genet; 2017 Jul; 60(7):395-398. PubMed ID: 28455154
[TBL] [Abstract][Full Text] [Related]
14. The novel duplication HRAS c.186_206dup p.(Glu62_Arg68dup): clinical and functional aspects.
Gripp KW; Baker L; Robbins KM; Stabley DL; Bellus GA; Kolbe V; Nauth T; Rosenberger G
Eur J Hum Genet; 2020 Nov; 28(11):1548-1554. PubMed ID: 32499600
[TBL] [Abstract][Full Text] [Related]
15. Respiratory system involvement in Costello syndrome.
Gomez-Ospina N; Kuo C; Ananth AL; Myers A; Brennan ML; Stevenson DA; Bernstein JA; Hudgins L
Am J Med Genet A; 2016 Jul; 170(7):1849-57. PubMed ID: 27102959
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic analysis of individuals with Costello syndrome due to HRAS p.G13C.
Gripp KW; Hopkins E; Sol-Church K; Stabley DL; Axelrad ME; Doyle D; Dobyns WB; Hudson C; Johnson J; Tenconi R; Graham GE; Sousa AB; Heller R; Piccione M; Corsello G; Herman GE; Tartaglia M; Lin AE
Am J Med Genet A; 2011 Apr; 155A(4):706-16. PubMed ID: 21438134
[TBL] [Abstract][Full Text] [Related]
17. Novel pathogenic variant in the HRAS gene with lethal outcome and a broad phenotypic spectrum among Polish patients with Costello syndrome.
Pelc M; Ciara E; Jezela-Stanek A; Kugaudo M; Cieślikowska A; Jurkiewicz D; Janeczko M; Chrzanowska K; Krajewska-Walasek M; Skórka A
Clin Dysmorphol; 2017 Apr; 26(2):83-90. PubMed ID: 28027064
[TBL] [Abstract][Full Text] [Related]
18. Paternal uniparental disomy 11p15.5 in the pancreatic nodule of an infant with Costello syndrome: Shared mechanism for hyperinsulinemic hypoglycemia in neonates with Costello and Beckwith-Wiedemann syndrome and somatic loss of heterozygosity in Costello syndrome driving clonal expansion.
Gripp KW; Robbins KM; Sheffield BS; Lee AF; Patel MS; Yip S; Doyle D; Stabley D; Sol-Church K
Am J Med Genet A; 2016 Mar; 170(3):559-64. PubMed ID: 26572961
[TBL] [Abstract][Full Text] [Related]
19. Retinal dystrophy in two boys with Costello syndrome due to the HRAS p.Gly13Cys mutation.
Pierpont ME; Richards M; Engel WK; Mendelsohn NJ; Summers CG
Am J Med Genet A; 2017 May; 173(5):1342-1347. PubMed ID: 28337834
[TBL] [Abstract][Full Text] [Related]
20. A novel HRAS substitution (c.266C>G; p.S89C) resulting in decreased downstream signaling suggests a new dimension of RAS pathway dysregulation in human development.
Gripp KW; Bifeld E; Stabley DL; Hopkins E; Meien S; Vinette K; Sol-Church K; Rosenberger G
Am J Med Genet A; 2012 Sep; 158A(9):2106-18. PubMed ID: 22821884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
